valproic acid has been researched along with bisindolylmaleimide i in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chen, G; Hawver, DB; Manji, HK; Potter, WZ; Yuan, P | 1 |
Grimes, CA; Jope, RS | 1 |
2 other study(ies) available for valproic acid and bisindolylmaleimide i
Article | Year |
---|---|
Increase in AP-1 transcription factor DNA binding activity by valproic acid.
Topics: Activating Transcription Factor 2; Animals; Anticonvulsants; Brain; Cyclic AMP Response Element-Binding Protein; Cycloheximide; DNA, Neoplasm; Dose-Response Relationship, Drug; Glioma; Humans; Indoles; Maleimides; Neuroblastoma; Okadaic Acid; Phosphoprotein Phosphatases; Protein Kinase C; Protein Synthesis Inhibitors; Rats; Time Factors; Transcription Factor AP-1; Transcription Factors; Tumor Cells, Cultured; Valproic Acid | 1997 |
Cholinergic stimulation of early growth response-1 DNA binding activity requires protein kinase C and mitogen-activated protein kinase kinase activation and is inhibited by sodium valproate in SH-SY5Y cells.
Topics: Calcium-Calmodulin-Dependent Protein Kinases; Carbachol; DNA-Binding Proteins; DNA, Neoplasm; Early Growth Response Protein 1; Enzyme Activation; Enzyme Inhibitors; Flavonoids; Genistein; Humans; Immediate-Early Proteins; Indoles; Kinetics; Maleimides; MAP Kinase Kinase 1; MAP Kinase Kinase 2; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Mitogen-Activated Protein Kinase Kinases; Mitogen-Activated Protein Kinases; Neuroblastoma; Protein Kinase C; Protein Kinases; Protein Serine-Threonine Kinases; Protein-Tyrosine Kinases; Transcription Factors; Tumor Cells, Cultured; Valproic Acid | 1999 |